New drug shows promise in slowing kidney disease progression
NCT ID NCT07150338
First seen Nov 01, 2025 · Last updated May 07, 2026 · Updated 26 times
Summary
This completed study tested a new drug that targets energy use in cells to see if it could slow the loss of kidney function in people with chronic kidney disease (stages 3-5). The study included 45 adults whose kidney function was declining but not too rapidly. Researchers measured changes in kidney function and protein levels in urine over time to assess the drug's effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE (STAGE 3-4) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Premier Kidney clinic
Pasadena, Texas, 77504, United States
Conditions
Explore the condition pages connected to this study.